| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |